Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023 Nov 2, 2023 04:05PM
Adaptive Biotechnologies (ADPT) Announces Launch of Epic Integration for clonoSEQ Sep 13, 2023 07:31AM
Adaptive Announces Launch of Epic Integration for clonoSEQ® Sep 13, 2023 07:30AM
Adaptive Biotechnologies (ADPT) Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology May 9, 2023 07:31AM
Adaptive Biotechnologies Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology May 9, 2023 07:30AM
View Older Stories

Jul 28, 2022 07:30AM Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma
Jul 28, 2022 07:30AM Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma
Jul 8, 2022 04:05PM Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022
Jul 8, 2022 04:05PM Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022
Jun 15, 2022 07:30AM Adaptive Biotechnologies (ADPT) Launches T-Detect Lyme for Detection of Early Lyme Disease
Jun 15, 2022 07:30AM Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease
Jun 15, 2022 07:30AM Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease
Jun 2, 2022 04:10PM Adaptive Biotechnologies Included in Key Abstracts at ASCO 2022 Supporting the Role of the clonoSEQ® Assay as a Standard for MRD Assessment Technology
Jun 2, 2022 04:10PM Adaptive Biotechnologies Included in Key Abstracts at ASCO 2022 Supporting the Role of the clonoSEQ® Assay as a Standard for MRD Assessment Technology
May 2, 2022 04:05PM Adaptive Biotechnologies to Present at the BofA Securities 2022 Healthcare Conference
Apr 5, 2022 04:30PM Adaptive Biotechnologies to Report First Quarter Financial Results on May 4, 2022
Apr 5, 2022 04:30PM Adaptive Biotechnologies to Report First Quarter Financial Results on May 4, 2022
Mar 9, 2022 07:00AM Adaptive Biotechnologies (ADPT) Appoints Tycho Peterson as CFO
Mar 9, 2022 07:00AM Adaptive Biotechnologies Appoints Tycho Peterson as Chief Financial Officer, Reorganizes and Streamlines Workforce to Drive Growth in Two Key Business Areas
Mar 9, 2022 07:00AM Adaptive Biotechnologies Appoints Tycho Peterson as Chief Financial Officer, Reorganizes and Streamlines Workforce to Drive Growth in Two Key Business Areas
Mar 2, 2022 04:05PM Adaptive Biotechnologies to Present at the 42nd Annual Cowen Healthcare Conference
Mar 2, 2022 04:05PM Adaptive Biotechnologies to Present at the 42nd Annual Cowen Healthcare Conference
Feb 18, 2022 11:35AM Adaptive Biotechnologies (ADPT) Announces New Data Demonstrating ImmunoSEQ® Technology Can Identify T-Cell Receptors Associated with Crohn’s Disease
Feb 18, 2022 11:35AM Adaptive Biotechnologies Announces New Data Demonstrating ImmunoSEQ® Technology Can Identify T-Cell Receptors Associated with Crohn’s Disease
Feb 18, 2022 11:35AM Adaptive Biotechnologies Announces New Data Demonstrating ImmunoSEQ® Technology Can Identify T-Cell Receptors Associated with Crohn’s Disease
Jan 10, 2022 08:35AM Adaptive Biotechnologies (ADPT) Announces Preliminary Revenue Results, CFO Transition
Jan 10, 2022 08:30AM Adaptive Biotechnologies Announces Preliminary, Unaudited 2021 Revenue Results and CFO Transition
Jan 10, 2022 08:30AM Adaptive Biotechnologies Announces Preliminary, Unaudited 2021 Revenue Results and CFO Transition
Dec 13, 2021 04:08PM Adaptive Biotechnologies (ADPT) Reports New Data Demonstrating the Benefit of Serial MRD Testing with the clonoSEQ Assay in Patients with Blood Cancers
Dec 13, 2021 04:05PM Adaptive Biotechnologies Announces New Data Demonstrating the Benefit of Serial MRD Testing with the clonoSEQ® Assay in Patients with Blood Cancers at the 63rd ASH Annual Meeting
Dec 13, 2021 04:05PM Adaptive Biotechnologies Announces New Data Demonstrating the Benefit of Serial MRD Testing with the clonoSEQ® Assay in Patients with Blood Cancers at the 63rd ASH Annual Meeting
Dec 2, 2021 08:00AM Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting
Dec 2, 2021 08:00AM Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting
Nov 12, 2021 05:32AM Adaptive Biotechnologies (ADPT) Receives Updated Medicare Coverage for clonoSEQ
Nov 11, 2021 05:52PM Adaptive Biotechnologies Receives Updated Medicare Coverage for its Minimal Residual Disease (MRD) Assay, clonoSEQ® for Blood Cancer Patients
Nov 11, 2021 05:52PM Adaptive Biotechnologies Receives Updated Medicare Coverage for its Minimal Residual Disease (MRD) Assay, clonoSEQ® for Blood Cancer Patients
Oct 4, 2021 05:51AM Adaptive Biotechnologies (ADPT) Announces New Data Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme Disease
Oct 2, 2021 01:15PM Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme D
Oct 2, 2021 01:15PM Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme D
Sep 30, 2021 07:30AM Adaptive Biotechnologies Launches Enhanced clonoSEQ® Assay Reports for Patients with Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation Status
Sep 30, 2021 07:30AM Adaptive Biotechnologies Launches Enhanced clonoSEQ® Assay Reports for Patients with Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation Status
Sep 21, 2021 04:05PM Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footprint in Seattle
Sep 21, 2021 04:05PM Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footprint in Seattle
Sep 16, 2021 08:04AM Adaptive Biotechnologies (ADPT) Will Present New SARS-CoV-2 Data from its Immune Medicine Platform at IDWeek 2021
Sep 16, 2021 08:03AM Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021
Sep 16, 2021 08:03AM Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021
Aug 10, 2021 02:11PM Curebase, Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study Access
Aug 4, 2021 04:15PM Adaptive Biotechnologies Appoints Nitin Sood as Chief Commercial Officer
Aug 4, 2021 04:15PM Adaptive Biotechnologies Appoints Nitin Sood as Chief Commercial Officer
Jun 9, 2021 07:15AM New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern
Jun 9, 2021 07:15AM New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern
Jun 3, 2021 07:30AM Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients
Jun 3, 2021 07:30AM Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients
Mar 17, 2021 04:09PM Adaptive Biotechnologies (ADPT) Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen
Mar 17, 2021 04:05PM Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen
View Older Stories